top of page

BIO Chairman and Nkarta CEO talks biotech

Current BIO Chairman and Nkarta CEO Paul Hastings talks about the policy changes that have been affecting biotech lately, and the science and clinical experience of NK cells vs T-cells.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page